Panagora Asset Management’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-186,865
Closed -$37K 2443
2017
Q3
$37K Buy
+186,865
New +$37K ﹤0.01% 2106
2014
Q2
Sell
-11,376
Closed -$342K 2435
2014
Q1
$342K Buy
+11,376
New +$383K ﹤0.01% 1567

Panagora Asset Management's WINT Position: Q4 2017 in Review

Panagora Asset Management sold out of Windtree Therapeutics Inc (WINT) in Q4 2017, closing a stake of 186,865 shares — an estimated $37K sold.

Panagora Asset Management first reported a position in WINT in Q1 2014 and held it in 2 quarters. The position peaked at $342K in Q1 2014. 0 funds tracked by Wall St. Rank hold WINT as of Q4 2017.

  • Panagora Asset Management reported no remaining Windtree Therapeutics Inc position as of Q4 2017 after selling out during the quarter.
  • Panagora Asset Management sold 186,865 Windtree Therapeutics Inc shares in Q4 2017, an estimated $37K.
  • Panagora Asset Management first reported a position in Windtree Therapeutics Inc in Q1 2014 and held it in 2 quarters.
  • Panagora Asset Management's Windtree Therapeutics Inc position peaked at $342K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2017.

Based on Panagora Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.